These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26455327)

  • 41. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.
    Zoratti GL; Tanabe LM; Varela FA; Murray AS; Bergum C; Colombo É; Lang JE; Molinolo AA; Leduc R; Marsault E; Boerner J; List K
    Nat Commun; 2015 Apr; 6():6776. PubMed ID: 25873032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression.
    Ford NA; Nunez NP; Holcomb VB; Hursting SD
    Endocr Relat Cancer; 2013 Feb; 20(1):39-51. PubMed ID: 23152442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesteryl Ester Promotes Mammary Tumor Growth in MMTV-PyMT Mice and Activates Akt-mTOR Pathway in Tumor Cells.
    Wei L; Lu X; Weng S; Zhu S; Chen Y
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34201030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.
    Polo ML; Riggio M; May M; Rodríguez MJ; Perrone MC; Stallings-Mann M; Kaen D; Frost M; Goetz M; Boughey J; Lanari C; Radisky D; Novaro V
    Oncotarget; 2015 Sep; 6(26):22081-97. PubMed ID: 26098779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
    Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
    Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
    Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
    Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly specific role of the insulin receptor in breast cancer progression.
    Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
    Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression.
    Park SY; Kim JH; Lee YJ; Lee SJ; Kim Y
    Int J Oncol; 2013 Jan; 42(1):287-96. PubMed ID: 23151889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of PDK1 in maintaining immune cell development and function.
    Huang Y; Feng Q; Zhang Y; Zeng Y; Shi N; Chen Y; Tang X; Li Z
    Biochem Biophys Res Commun; 2024 Aug; 721():150106. PubMed ID: 38795634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyanidin inhibits EMT induced by oxaliplatin via targeting the PDK1-PI3K/Akt signaling pathway.
    Li X; Zhang ZS; Zhang XH; Yang SN; Liu D; Diao CR; Wang H; Zheng FP
    Food Funct; 2019 Feb; 10(2):592-601. PubMed ID: 30672917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PDK1 regulates the survival of the developing cortical interneurons.
    Wei Y; Han X; Zhao C
    Mol Brain; 2020 May; 13(1):65. PubMed ID: 32366272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical analysis of PDK1 expression in breast cancer.
    Arsenic R
    Diagn Pathol; 2014 Apr; 9():82. PubMed ID: 24739482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer.
    Yeo SK; Paul R; Haas M; Wang C; Guan JL
    Autophagy; 2018; 14(7):1214-1225. PubMed ID: 29938573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PDK1: At the crossroad of cancer signaling pathways.
    Gagliardi PA; Puliafito A; Primo L
    Semin Cancer Biol; 2018 Feb; 48():27-35. PubMed ID: 28473254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PDK1 Deficit Impairs the Development of the Dentate Gyrus in Mice.
    Xu M; Han X; Liu R; Li Y; Qi C; Yang Z; Zhao C; Gao J
    Cereb Cortex; 2019 Mar; 29(3):1185-1198. PubMed ID: 29420689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.